TwelveStone Health Partners: Comprehensive Company Profile

Background

TwelveStone Health Partners, established in 2016 and headquartered in Murfreesboro, Tennessee, is a faith-driven healthcare organization dedicated to supporting patients with chronic and complex conditions. The company's mission is to glorify God by delivering exceptional care experiences, facilitating transitions from acute to post-acute care environments, and guiding patients from sickness to health. With a legacy dating back to 1980, TwelveStone has evolved from a single retail pharmacy into a comprehensive provider of chronic care medication services, including specialty pharmacy, infusion services, and durable medical equipment.

Key Strategic Focus

TwelveStone's strategic focus centers on delivering integrated solutions tailored for patients with chronic conditions. The company specializes in:

Specialty Pharmacy Services: Providing access to advanced medications for conditions such as Multiple Sclerosis, Cystic Fibrosis, Hemophilia, and Crohn's Disease.

Infusion Services: Offering both home-based and center-based infusion therapies in spa-like environments to enhance patient comfort.

Durable Medical Equipment: Supplying essential medical equipment to support patient care at home.

By integrating these services, TwelveStone aims to simplify treatment processes, reduce administrative burdens for healthcare providers, and improve patient adherence and outcomes.

Financials and Funding

TwelveStone Health Partners has demonstrated consistent financial growth, evidenced by its inclusion in the Inc. 5000 list of fastest-growing private companies for five consecutive years. In 2024, the company ranked No. 3,810, achieving a three-year revenue growth of 121%.

The company has secured significant funding to support its expansion initiatives:

2017: Received a $3.35 million investment from Claritas Capital to accelerate expansion plans and develop an end-to-end technology platform for chronic care management.

2021: Secured $12 million from Siena Healthcare Finance to expand its network of infusion centers across Tennessee and the Southeast.

Pipeline Development

TwelveStone is actively expanding its network of infusion centers to enhance patient access to care. Recent developments include:

2025: Opened a new infusion center in Bowling Green, Kentucky, marking the company's 23rd location.

2023: Established infusion centers in Norfolk and Dulles, Virginia, and multiple locations in Georgia, including Lithonia, Duluth, Cumming, Smyrna, and Peachtree City.

These expansions reflect TwelveStone's commitment to providing accessible, community-based care for patients managing chronic conditions.

Technological Platform and Innovation

TwelveStone leverages advanced technologies to enhance patient care and operational efficiency:

Financial Assistance Solutions: In 2023, the company partnered with TailorMed to implement a platform that identifies and secures financial assistance for patients, addressing affordability challenges associated with high-cost medications.

Integrated Care Coordination: Utilizes technology to streamline communication between patients, providers, and payers, ensuring adherence to care plans and reducing hospital readmissions.

Leadership Team

TwelveStone's leadership comprises experienced professionals dedicated to advancing the company's mission:

Shane Reeves, PharmD: Chief Executive Officer

Oversees all aspects of the business, leveraging extensive experience in pharmacy and healthcare services.

Jay McKnight: President

Brings a background in healthcare financial leadership, including roles as CFO and CEO of Diversicare Healthcare Services.

Dave Carter: Chief Revenue Officer

Leads sales activities and strategic partnerships, with experience in healthcare and media industries.

Jozef Nuyens: Chief Strategy Officer

A serial entrepreneur with expertise in international business and strategic forecasting.

Cannon Loughry: Chief Operating Officer

Manages company operations, with a background in healthcare technology strategy.

Lee Golden, PharmD: Chief Clinical Officer

Oversees pharmacy-related solutions and services, focusing on clinical excellence.

Clint Hill: Chief Financial Officer

Amanda Cecconi: Chief Marketing Officer

Manages marketing and communications, with extensive experience in brand development and lead generation.

Leadership Changes

In 2023, Jay McKnight joined TwelveStone as President, bringing experience from his previous roles at Varsity Healthcare Partners and Diversicare Healthcare Services.

Competitor Profile

Market Insights and Dynamics

The healthcare services industry, particularly in chronic care management and infusion services, is experiencing significant growth due to the increasing prevalence of chronic diseases and the demand for specialized care. The market is characterized by a shift towards outpatient and home-based care models, emphasizing patient convenience and cost-effectiveness.

Competitor Analysis

TwelveStone operates in a competitive landscape with several notable companies:

Boiron: A pharmaceutical laboratory specializing in homeopathic medicines.

Abiomed: Provides medical devices for circulatory support.

Ali Raif and Seriki: Manufactures pharmaceutical products.

B. Braun Medical: Specializes in infusion therapy and pain management.

These competitors offer a range of services and products that intersect with TwelveStone's offerings, particularly in the areas of infusion therapy and pharmaceutical services.

Strategic Collaborations and Partnerships

TwelveStone has established significant partnerships to enhance its service offerings:

TailorMed Collaboration (2023): Implemented a platform to improve medication access and affordability by connecting patients with financial assistance programs.

Claritas Capital Investment (2017): Received $3.35 million to accelerate expansion and develop a technology platform for chronic care management.

Siena Healthcare Finance Funding (2021): Secured $12 million to expand infusion center locations across the Southeast.

Operational Insights

TwelveStone differentiates itself through a patient-centric approach, integrating specialty pharmacy, infusion services, and durable medical equipment to provide comprehensive care. The company's expansion into multiple states and the establishment of numerous infusion centers demonstrate its commitment to accessibility and community-based care. By leveraging technology and strategic partnerships, TwelveStone enhances patient outcomes and streamlines care coordination.

Strategic Opportunities and Future Directions

Looking ahead, TwelveStone aims to:

Expand Geographic Reach: Continue opening infusion centers in underserved regions to increase access to care.

Enhance Technological Capabilities: Invest in advanced platforms for patient engagement and care coordination.

Strengthen Partnerships: Collaborate with healthcare providers and payers to develop integrated care models.

By building on its current strengths and strategic initiatives, TwelveStone is well-positioned to address the evolving needs of patients with chronic conditions and to navigate the dynamic healthcare landscape.